论文部分内容阅读
盐野义公司的碳青霉烯类抗生素doripenem(暂译名:多立培南)注射剂,在日本获得全球首次推荐批准。早在2003年9月,这个β-内酰胺类药物就已提出新药申请用于广谱
Saline Yokoyama’s carbapenem antibiotic doripenem (provisional translation: Doripenem) injection, the world’s first recommended for approval in Japan. As early as September 2003, this beta-lactam has been proposed for a new drug application for a broad spectrum